The Claim
Apigenin reduces lipid accumulation in mouse 3T3-L1 adipocytes by downregulating the expression of PPARγ, aP2, and stearoyl-CoA desaturase, demonstrating a transcriptional mechanism that inhibits fat storage in vitro.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin decreases fat buildup in mouse fat cells by lowering the activity of specific genes—PPARγ, aP2, and stearoyl-CoA desaturase—that control fat storage.
See the scientific wording
Apigenin reduces lipid accumulation in mouse 3T3-L1 adipocytes by downregulating key adipogenic genes including PPARγ, aP2, and stearoyl-CoA desaturase, indicating a transcriptional mechanism for inhibiting fat storage in vitro.
Apigenin enters fat cells and turns on a cellular energy sensor called AMPK, which shuts down the master switch for fat storage called PPARγ. When PPARγ is turned off, the cell stops making proteins that build and store fat, so less fat accumulates inside the cell.
What the research says
1 studyStudy: Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells.
Apigenin, a plant compound, makes fat cells store less fat by turning down the genes that tell the cells to make and store fat, without turning on genes that break fat down — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.